These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30218742)

  • 21. Timing of initial cereal exposure in infancy and risk of islet autoimmunity.
    Norris JM; Barriga K; Klingensmith G; Hoffman M; Eisenbarth GS; Erlich HA; Rewers M
    JAMA; 2003 Oct; 290(13):1713-20. PubMed ID: 14519705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GAD antibodies in T1D and LADA--relations to age, BMI, c-peptide, IA-2 and HLA-DRB1*03 and DRB1*04 alleles.
    Weber P; Ambrosova P; Canov P; Weberova D; Kuklinek P; Meluzinova H; Matejovska-Kubesova H; Cejkova P; Bielakova K; Cerna M
    Adv Gerontol; 2011; 24(2):312-8. PubMed ID: 21957594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-DR-DQ haplotypes and specificity of the initial autoantibody in islet specific autoimmunity.
    Mikk ML; Pfeiffer S; Kiviniemi M; Laine AP; Lempainen J; Härkönen T; Toppari J; Veijola R; Knip M; Ilonen J;
    Pediatr Diabetes; 2020 Nov; 21(7):1218-1226. PubMed ID: 32613719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial remission in Brazilian children and adolescents with type 1 diabetes. Association with a haplotype of class II human leukocyte antigen and synthesis of autoantibodies.
    Camilo DS; Pradella F; Paulino MF; Baracat ECE; Marini SH; Guerra G; Pavin EJ; Parisi C; Longhini ALF; Marques SB; Guariento EG; Lieber SR; Macedo CF; Gama E Silva L; Farias AS; Santos LMB; Volpini WMG
    Pediatr Diabetes; 2020 Jun; 21(4):606-614. PubMed ID: 32078220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry.
    Decochez K; Tits J; Coolens JL; Van Gaal L; Krzentowski G; Winnock F; Anckaert E; Weets I; Pipeleers DG; Gorus FK
    Diabetes Care; 2000 Jun; 23(6):838-44. PubMed ID: 10841006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The KAG motif of HLA-DRB1 (β71, β74, β86) predicts seroconversion and development of type 1 diabetes.
    Zhao LP; Papadopoulos GK; Lybrand TP; Moustakas AK; Bondinas GP; Carlsson A; Larsson HE; Ludvigsson J; Marcus C; Persson M; Samuelsson U; Wang R; Pyo CW; Nelson WC; Geraghty DE; Rich SS; Lernmark Å;
    EBioMedicine; 2021 Jul; 69():103431. PubMed ID: 34153873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glutamic acid decarboxylase 65 and islet cell antigen 512/IA-2 autoantibodies in relation to human leukocyte antigen class II DR and DQ alleles and haplotypes in type 1 diabetes mellitus.
    Stayoussef M; Benmansour J; Al-Jenaidi FA; Said HB; Rayana CB; Mahjoub T; Almawi WY
    Clin Vaccine Immunol; 2011 Jun; 18(6):990-3. PubMed ID: 21490167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in Zinc Transporter 8 Autoantibodies Following Type 1 Diabetes Onset: The Type 1 Diabetes Genetics Consortium Autoantibody Workshop.
    Wenzlau JM; Frisch LM; Hutton JC; Fain PR; Davidson HW
    Diabetes Care; 2015 Oct; 38 Suppl 2(Suppl 2):S14-20. PubMed ID: 26405067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology, clinical aspects, and biology of IDDM patients under age 40 years. Comparison of data from Antwerp with complete ascertainment with data from Belgium with 40% ascertainment. The Belgian Diabetes Registry.
    Vandewalle CL; Coeckelberghs MI; De Leeuw IH; Du Caju MV; Schuit FC; Pipeleers DG; Gorus FK
    Diabetes Care; 1997 Oct; 20(10):1556-61. PubMed ID: 9314635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Types of pediatric diabetes mellitus defined by anti-islet autoimmunity and random C-peptide at diagnosis.
    Redondo MJ; Rodriguez LM; Escalante M; Smith EO; Balasubramanyam A; Haymond MW
    Pediatr Diabetes; 2013 Aug; 14(5):333-40. PubMed ID: 23458188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autoantibodies to islet antigen-2 are associated with HLA-DRB1*07 and DRB1*09 haplotypes as well as DRB1*04 at onset of type 1 diabetes: the possible role of HLA-DQA in autoimmunity to IA-2.
    Williams AJ; Aitken RJ; Chandler MA; Gillespie KM; Lampasona V; Bingley PJ
    Diabetologia; 2008 Aug; 51(8):1444-8. PubMed ID: 18504544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ATPase4A Autoreactivity and Its Association With Autoimmune Phenotypes in the Type 1 Diabetes Genetics Consortium Study.
    Wenzlau JM; Fain PR; Gardner TJ; Frisch LM; Annibale B; Hutton JC
    Diabetes Care; 2015 Oct; 38 Suppl 2(Suppl 2):S29-36. PubMed ID: 26405069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DPD epitope-specific glutamic acid decarboxylase (GAD)65 autoantibodies in children with Type 1 diabetes.
    Bansal N; Hampe CS; Rodriguez L; O'Brian Smith E; Kushner J; Balasubramanyam A; Redondo MJ
    Diabet Med; 2017 May; 34(5):641-646. PubMed ID: 26802570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
    Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune and clinical characteristics of type I diabetes in children with different genetic risk loads defined by HLA-DQB1 alleles. Childhood Diabetes in Finland Study Group.
    Komulainen J; Knip M; Sabbah E; Vähäsalo P; Lounamaa R; Akerblom HK; Reijonen H; Ilonen J
    Clin Sci (Lond); 1998 Mar; 94(3):263-9. PubMed ID: 9616260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study).
    Takeda H; Kawasaki E; Shimizu I; Konoue E; Fujiyama M; Murao S; Tanaka K; Mori K; Tarumi Y; Seto I; Fujii Y; Kato K; Kondo S; Takada Y; Kitsuki N; Kaino Y; Kida K; Hashimoto N; Yamane Y; Yamawaki T; Onuma H; Nishimiya T; Osawa H; Saito Y; Makino H;
    Diabetes Care; 2002 Jun; 25(6):995-1001. PubMed ID: 12032105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.
    Horton V; Stratton I; Bottazzo GF; Shattock M; Mackay I; Zimmet P; Manley S; Holman R; Turner R
    Diabetologia; 1999 May; 42(5):608-16. PubMed ID: 10333055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-related islet autoantibody incidence in offspring of patients with type 1 diabetes.
    Ziegler AG; Bonifacio E;
    Diabetologia; 2012 Jul; 55(7):1937-43. PubMed ID: 22289814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Ilonen J; Akerblom HK; Knip M
    Clin Exp Immunol; 1999 Apr; 116(1):78-83. PubMed ID: 10209508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early childhood CMV infection may decelerate the progression to clinical type 1 diabetes.
    Ekman I; Vuorinen T; Knip M; Veijola R; Toppari J; Hyöty H; Kinnunen T; Ilonen J; Lempainen J
    Pediatr Diabetes; 2019 Feb; 20(1):73-77. PubMed ID: 30338642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.